PharmaCyte Biotech Inc.

NASDAQ: PMCB · Real-Time Price · USD
1.02
0.12 (13.35%)
At close: Aug 18, 2025, 3:59 PM
1.02
0.00%
Pre-market: Aug 19, 2025, 07:00 AM EDT

PharmaCyte Biotech Balance Sheet Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Cash & Equivalents
15.17M 50.18M 68.04M 85.4M 2.2M
Short-Term Investments
366.32K n/a n/a n/a n/a
Long-Term Investments
22.47M 7.91M 1.57M 1.57M 1.57M
Other Long-Term Assets
8.77M 7.69K 7.69K 7.69K 7.37K
Receivables
3.7M n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a
Other Current Assets
3.14M 259.8K n/a n/a n/a
Total Current Assets
22.38M 50.44M 68.15M 85.49M 2.28M
Property-Plant & Equipment
n/a n/a n/a n/a n/a
Goodwill & Intangibles
1.55M 1.55M 3.55M 3.55M 3.55M
Total Long-Term Assets
32.79M 9.46M 5.13M 5.13M 5.13M
Total Assets
55.17M 59.9M 73.28M 90.62M 7.4M
Account Payables
399.2K 389.37K 128.28K 205.36K 172.26K
Deferred Revenue
n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a 50.8K
Other Current Liabilities
n/a 6.73M 345.41K 380.95K n/a
Total Current Liabilities
2.91M 7.42M 586.58K 704.37K 724.78K
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
363K 12.97M n/a n/a n/a
Total Long-Term Liabilities
363K 12.97M n/a n/a n/a
Total Liabilities
3.28M 20.39M 586.58K 704.37K 724.78K
Total Debt
n/a n/a n/a n/a 50.8K
Common Stock
2.17K 2.17K 2.16K 2.07K 159.00
Retained Earnings
-84.97M -115.63M -115.96M -111.65M -107.41M
Comprehensive Income
-23.87K -23.51K -23K -15.76K -20.38K
Shareholders Equity
51.89M 39.51M 72.69M 89.92M 6.68M
Total Investments
22.84M 7.91M 1.57M 1.57M 1.57M